229 related articles for article (PubMed ID: 19567529)
1. X-chromosome gene dosage and the risk of diabetes in Turner syndrome.
Bakalov VK; Cheng C; Zhou J; Bondy CA
J Clin Endocrinol Metab; 2009 Sep; 94(9):3289-96. PubMed ID: 19567529
[TBL] [Abstract][Full Text] [Related]
2. Analysis of genetic variability in Turner syndrome linked to long-term clinical features.
Suntharalingham JP; Ishida M; Cameron-Pimblett A; McGlacken-Byrne SM; Buonocore F; Del Valle I; Madhan GK; Brooks T; Conway GS; Achermann JC
Front Endocrinol (Lausanne); 2023; 14():1227164. PubMed ID: 37800145
[TBL] [Abstract][Full Text] [Related]
3. X-chromosome gene dosage as a determinant of impaired pre and postnatal growth and adult height in Turner syndrome.
Fiot E; Zenaty D; Boizeau P; Haigneré J; Dos Santos S; Léger J;
Eur J Endocrinol; 2016 Mar; 174(3):281-8. PubMed ID: 26744895
[TBL] [Abstract][Full Text] [Related]
4. Bicuspid aortic valve and aortic coarctation are linked to deletion of the X chromosome short arm in Turner syndrome.
Bondy C; Bakalov VK; Cheng C; Olivieri L; Rosing DR; Arai AE
J Med Genet; 2013 Oct; 50(10):662-5. PubMed ID: 23825392
[TBL] [Abstract][Full Text] [Related]
5. Increased Prevalence of Beta-Cell Dysfunction despite Normal HbA1c in Youth and Young Adults with Turner Syndrome.
Sheanon N; Elder D; Khoury J; Casnellie L; Gutmark-Little I; Cernich J; Backeljauw PF
Horm Res Paediatr; 2021; 94(7-8):297-306. PubMed ID: 34657042
[TBL] [Abstract][Full Text] [Related]
6. Hyperglycemia in Turner syndrome: Impact, mechanisms, and areas for future research.
Mitsch C; Alexandrou E; Norris AW; Pinnaro CT
Front Endocrinol (Lausanne); 2023; 14():1116889. PubMed ID: 36875465
[TBL] [Abstract][Full Text] [Related]
7. Cognition and the sex chromosomes: studies in Turner syndrome.
Ross J; Roeltgen D; Zinn A
Horm Res; 2006; 65(1):47-56. PubMed ID: 16397401
[TBL] [Abstract][Full Text] [Related]
8. An isolated Xp deletion is linked to autoimmune diseases in Turner syndrome.
Stoklasova J; Zapletalova J; Frysak Z; Hana V; Cap J; Pavlikova M; Soucek O; Lebl J
J Pediatr Endocrinol Metab; 2019 May; 32(5):479-488. PubMed ID: 31075085
[TBL] [Abstract][Full Text] [Related]
9. Integrated functional genomic analyses of Klinefelter and Turner syndromes reveal global network effects of altered X chromosome dosage.
Zhang X; Hong D; Ma S; Ward T; Ho M; Pattni R; Duren Z; Stankov A; Bade Shrestha S; Hallmayer J; Wong WH; Reiss AL; Urban AE
Proc Natl Acad Sci U S A; 2020 Mar; 117(9):4864-4873. PubMed ID: 32071206
[TBL] [Abstract][Full Text] [Related]
10. Isochromosome Xq and the risk of metabolic comorbidities in Turner syndrome.
Malhotra R; Shukla R; Rastogi V; Khadgawat R
Diabetes Metab Syndr; 2023 Feb; 17(2):102708. PubMed ID: 36696722
[TBL] [Abstract][Full Text] [Related]
11. X chromosome gene dosage as a determinant of congenital malformations and of age-related comorbidity risk in patients with Turner syndrome, from childhood to early adulthood.
Fiot E; Zénaty D; Boizeau P; Haignere J; Dos Santos S; Léger J;
Eur J Endocrinol; 2019 Jun; 180(6):397-406. PubMed ID: 30991358
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatic analysis identifies the immunological profile of turner syndrome with different X chromosome origins.
Qi X; Wang Q; Yu M; Kong Y; Shi F; Wang S
Front Endocrinol (Lausanne); 2023; 14():1024244. PubMed ID: 36733527
[TBL] [Abstract][Full Text] [Related]
13. New insights into clinical features, karyotypes, and age at diagnosis in women with Turner syndrome.
Frelich J; Irzyniec T; Lepska K; Jeż W
Endokrynol Pol; 2019; 70(4):342-349. PubMed ID: 31073987
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune disorders in women with turner syndrome and women with karyotypically normal primary ovarian insufficiency.
Bakalov VK; Gutin L; Cheng CM; Zhou J; Sheth P; Shah K; Arepalli S; Vanderhoof V; Nelson LM; Bondy CA
J Autoimmun; 2012 Jun; 38(4):315-21. PubMed ID: 22342295
[TBL] [Abstract][Full Text] [Related]
15. Impaired insulin secretion in the Turner metabolic syndrome.
Bakalov VK; Cooley MM; Quon MJ; Luo ML; Yanovski JA; Nelson LM; Sullivan G; Bondy CA
J Clin Endocrinol Metab; 2004 Jul; 89(7):3516-20. PubMed ID: 15240640
[TBL] [Abstract][Full Text] [Related]
16. Autosomal and X chromosome structural variants are associated with congenital heart defects in Turner syndrome: The NHLBI GenTAC registry.
Prakash SK; Bondy CA; Maslen CL; Silberbach M; Lin AE; Perrone L; Limongelli G; Michelena HI; Bossone E; Citro R; ; Lemaire SA; Body SC; Milewicz DM
Am J Med Genet A; 2016 Dec; 170(12):3157-3164. PubMed ID: 27604636
[TBL] [Abstract][Full Text] [Related]
17. An evaluation of early cardiometabolic risk factors in children and adolescents with Turner syndrome.
O'Gorman CS; Syme C; Lang J; Bradley TJ; Wells GD; Hamilton JK
Clin Endocrinol (Oxf); 2013 Jun; 78(6):907-13. PubMed ID: 23106295
[TBL] [Abstract][Full Text] [Related]
18. Immunological Profile and Autoimmunity in Turner Syndrome.
Kanakatti Shankar R
Horm Res Paediatr; 2020; 93(7-8):415-422. PubMed ID: 33503638
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal mosaicism mitigates stigmata and cardiovascular risk factors in Turner syndrome.
El-Mansoury M; Barrenäs ML; Bryman I; Hanson C; Larsson C; Wilhelmsen L; Landin-Wilhelmsen K
Clin Endocrinol (Oxf); 2007 May; 66(5):744-51. PubMed ID: 17381484
[TBL] [Abstract][Full Text] [Related]
20. Karyotype-specific ear and hearing problems in young adults with Turner syndrome and the effect of oxandrolone treatment.
Verver EJ; Freriks K; Sas TC; Huygen PL; Pennings RJ; Smeets DF; Hermus AR; Menke LA; Wit JM; Otten BJ; van Alfen-van der Velden JA; de Muinck Keizer-Schrama SM; Topsakal V; Admiraal RJ; Timmers HJ; Kunst HP
Otol Neurotol; 2014 Oct; 35(9):1577-84. PubMed ID: 25133471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
